1. Park JJ, Lee CJ, Park SJ, et al. Heart failure statistics in Korea, 2020: a report from the Korean Society of Heart Failure. Int J Heart Fail 2021;3:224–236.

2. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation 2022;145:e876–e894.

3. Park CS, Cho HJ, Choi EK, et al. J-curve relationship between corrected QT interval and mortality in acute heart failure patients. Korean J Intern Med 2020;35:1371–1384.

4. Maddox TM, Januzzi JL Jr, Allen LA, et al. 2021 update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2021;77:772–810.

5. Seo WW, Park JJ, Park HA, et al. Guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a cohort study. BMJ Open 2020;10:e030514.

6. Greene SJ, Butler J, Albert NM, et al. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry. J Am Coll Cardiol 2018;72:351–366.

7. Lee SE, Lee HY, Cho HJ, et al. Clinical characteristics and outcome of acute heart failure in Korea: results from the Korean Acute Heart Failure Registry (KorAHF). Korean Circ J 2017;47:341–353.

8. Basoor A, Doshi NC, Cotant JF, et al. Decreased readmissions and improved quality of care with the use of an inexpensive checklist in heart failure. Congest Heart Fail 2013;19:200–6.

9. Rismiati H, Lee KS, Kang J, Cho HJ, Lee HY. The role of discharge checklist in guideline-directed medical therapy for heart failure patients. Korean J Intern Med 2023;38:195–206.

10. Hyun J, Cho JY, Youn JC, et al. Korean Society of Heart Failure guidelines for the management of heart failure: advanced and acute heart failure. Int J Heart Fail 2023;5:111–126.

11. Cho JY, Cho DH, Youn JC, et al. Korean Society of Heart Failure Guidelines for the management of heart failure: definition and diagnosis. Int J Heart Fail 2023;5:51–65.

12. Choi HM, Park MS, Youn JC. Update on heart failure management and future directions. Korean J Intern Med 2019;34:11–43.

13. Beyene J, Atenafu EG, Hamid JS, To T, Sung L. Determining relative importance of variables in developing and validating predictive models. BMC Med Res Methodol 2009;9:64.

14. Mannan H. A practical application of a simple bootstrapping method for assessing predictors selected for epidemiologic risk models using automated variable selection. Int J Stat Appl 2017;7:239–249. 15. Youn JC, Kim D, Cho JY, et al. Korean Society of Heart Failure guidelines for the management of heart failure: treatment. Int J Heart Fail 2023;5:66–81.

16. Park SM, Lee SY, Jung MH, et al. Korean Society of Heart Failure guidelines for the management of heart failure: management of the underlying etiologies and comorbidities of heart failure. Int J Heart Fail 2023;5:127–145.

17. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation 2023;147:e93–e621.

18. Shah KS, Xu H, Matsouaka RA, et al. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol 2017;70:2476–2486.

19. Mebazaa A, Davison B, Chioncel O, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet 2022;400:1938–1952.

20. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2007;153:1021–1028.

21. Atherton JJ, Hayward CS, Wan Ahmad WA, et al. Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific). J Card Fail 2012;18:82–88.

22. Kaul U, Das MK, Agarwal R, et al. Consensus and development of document for management of stabilized acute decompensated heart failure with reduced ejection fraction in India. Indian Heart J 2020;72:477–481.

23. Kocabaş U, Ergin I, Kıvrak T, et al. Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction. ESC Heart Fail 2023;10:3677–3689.

24. Margolin E, Huynh T, Brann A, Greenberg B. Determinants of guideline-directed medical therapy implementation during heart failure hospitalization. JACC Adv 2024;3:100818.

25. Hein AM, Scialla JJ, Edmonston D, Cooper LB, DeVore AD, Mentz RJ. Medical management of heart failure with reduced ejection fraction in patients with advanced renal disease. JACC Heart Fail 2019;7:371–382.